Adenocancer

Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations

Issue: 

Vol 69, Issue 3: 2021

DOI: 

10.7727/wimj.2016.096

Pages: 

148-53

ABSTRACT

Received: 

10 Mar, 2016

Accepted: 

25 May, 2016

Published: 

31 Jul, 2021

PDF Attachment: 

wimj-iss3-2021_148_153.pdf

Journal Sections: 

Case Reports

Keywords: 

Adenocancer

anaplastic lymphoma kinase

Crizotinib

lung epidermal growth factor receptor mutation

Journal Authors: 

S Cokmert

A Veral

N Akyurek

SD Kececi

O Sivrikoz

E Yilmaz

O Tanriverdi

U Coskun

e-Published: 06 Jul, 2016

• Read more about Which Tyrosine Kinase Inhibitor Must We Apply Before? A Case Report of Crizotinib-resistant Patient with Concomitant EGFR and EML4-ALK Gene Mutations